Scholarlink

<p>Follow-up care for uterine malignancies aims to detect recurrence early, manage therapy-related late effects, and preserve quality of life. In clinical practice, taking a&#xa0;structured history of bleeding, pain and weight loss, as well as urinary and bowel symptoms, and performing a&#xa0;physical examination including speculum and rectovaginal palpation (with vaginal ultrasound if indicated) and symptom-guided diagnostics has proven effective. Routine imaging is only indicated in cases of clinical suspicion of endometrial or cervical carcinoma. Due to the high and early recurrence risk in sarcomas, clinical and imaging surveillance are both necessary. For cervical cancer, the focus is on pelvic recurrence, radiation-induced morbidity and vaginal stenosis. In endometrial cancer, recurrences occur locally and distantly with similar frequency and should be treated with curative intent when detected early. Routine tumor marker measurements should not be performed. Additionally, lymphedema, pain, fatigue, sexual function, and endocrinological issues should be actively addressed. Clear referral thresholds and a&#xa0;follow-up care passport facilitate cross-sector patient care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Nachsorge Uterusmalignome: worauf zu achten ist

  • 期刊论文

  • 发表日期：

    2026年1月16日

查看全文
  • Vincent Winkler,
  • Nicolai Maass,
  • Ibrahim Alkatout

摘要

Follow-up care for uterine malignancies aims to detect recurrence early, manage therapy-related late effects, and preserve quality of life. In clinical practice, taking a structured history of bleeding, pain and weight loss, as well as urinary and bowel symptoms, and performing a physical examination including speculum and rectovaginal palpation (with vaginal ultrasound if indicated) and symptom-guided diagnostics has proven effective. Routine imaging is only indicated in cases of clinical suspicion of endometrial or cervical carcinoma. Due to the high and early recurrence risk in sarcomas, clinical and imaging surveillance are both necessary. For cervical cancer, the focus is on pelvic recurrence, radiation-induced morbidity and vaginal stenosis. In endometrial cancer, recurrences occur locally and distantly with similar frequency and should be treated with curative intent when detected early. Routine tumor marker measurements should not be performed. Additionally, lymphedema, pain, fatigue, sexual function, and endocrinological issues should be actively addressed. Clear referral thresholds and a follow-up care passport facilitate cross-sector patient care.